[HTML][HTML] Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

S Stienlauf, V Yahalom, E Shinar, Y Sidi… - International Journal of …, 2013 - Elsevier
Objectives The natural history of blood donors infected with human T-lymphotropic virus type
1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel.

S Stienlauf, V Yahalom, E Shinar, Y Sidi… - … Journal of Infectious …, 2013 - europepmc.org
Objectives The natural history of blood donors infected with human T-lymphotropic virus type
1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

S Stienlauf, V Yahalom, E Shinar, Y Sidi… - International Journal of …, 2013 - infona.pl
The natural history of blood donors infected with human T-lymphotropic virus type 1 (HTLV-
1) in Israel has never been assessed. The aim of this study was to evaluate the prevalence …

Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

S Stienlauf, V Yahalom, E Shinar… - … publication of the …, 2013 - pubmed.ncbi.nlm.nih.gov
Objectives The natural history of blood donors infected with human T-lymphotropic virus type
1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel.

S Stienlauf, V Yahalom, E Shinar, Y Sidi, G Segal… - 2013 - cabidigitallibrary.org
Objectives: The natural history of blood donors infected with human T-lymphotropic virus
type 1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

[PDF][PDF] Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

S Stienlauf, V Yahalom, E Shinar, Y Sidi… - … Journal of Infectious …, 2013 - scholar.archive.org
Objectives: The natural history of blood donors infected with human T-lymphotropic virus
type 1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

[PDF][PDF] Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

S Stienlauf, V Yahalom, E Shinar, Y Sidi… - International Journal of …, 2013 - academia.edu
Objectives: The natural history of blood donors infected with human T-lymphotropic virus
type 1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

S Stienlauf, V Yahalom, E Shinar, Y Sidi… - International Journal of …, 2013 - ijidonline.com
Objectives The natural history of blood donors infected with human T-lymphotropic virus type
1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

[PDF][PDF] Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

S Stienlauf, V Yahalom, E Shinar, Y Sidi… - … Journal of Infectious …, 2013 - cyberleninka.org
Objectives: The natural history of blood donors infected with human T-lymphotropic virus
type 1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

[PDF][PDF] Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

S Stienlauf, V Yahalom, E Shinar, Y Sidi… - International Journal of …, 2013 - academia.edu
Objectives: The natural history of blood donors infected with human T-lymphotropic virus
type 1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …